Tag results:
myocardial infarction
Muscle Cell News
Activation of Autophagic Flux Blunts Cardiac Ischemia/Reperfusion Injury
[Circulation Research] Cultured neonatal rat ventricular myocytes (NRVMs) were exposed to Tat-Beclin during simulated ischemia/reperfusion injury. ATG7 knockdown by siRNA in NRVMs was used to evaluate the role of autophagy.
Umbilical & Placental Cell News
hAECs and Their Exosomes Improve Cardiac Function after Acute Myocardial Infarction in Rats
[Aging] Researchers cultured human amniotic epithelial cells (hAECs) and extracted exosomes from culture supernatants. They established a stable acute myocardial infarction model in rats and treated them with hAECs, exosomes, or PBS.
Muscle Cell News
MARK4 Controls Ischaemic Heart Failure through Microtubule Detyrosination
[Nature] Investigators presented how the detyrosination of microtubules in cardiomyocytes was finely tuned by microtubule-affinity regulating kinase 4 (MARK4) to regulate cardiac inotropy, and identified MARK4 as a promising therapeutic target for improving cardiac function after myocardial infarction.
Mesenchymal Cell News
Adropin-Based Dual Treatment Enhances the Therapeutic Potential of Mesenchymal Stem Cells in Rat Myocardial Infarction
[Cell Death & Disease] Adropin in vitro reduced hydrogen peroxide-induced apoptosis in rat bone marrow MSCs and improved MSCs survival with increased phosphorylation of Akt and extracellular regulated protein kinases.
Cell Therapy News
Injectable Hydrogel for Co-Delivery of 5-Azacytidine in Zein Protein Nanoparticles with Stem Cells for Cardiac Function Restoration
[International Journal of Pharmaceutics] Injectable alginate based microporous hydrogel were used to deliver 5-Azacytidine in zein protein nanoparticle with mesenchymal stem cells for attenuating adverse cardiac remodelling after myocardial infarction.
Muscle Cell News
Interplay between Inflammation and Thrombosis in Cardiovascular Pathology
[Nature Reviews Cardiology] Scientists discuss how the synergy between inflammation and thrombosis drives thrombotic diseases. They focus on the huge potential of anti-inflammatory strategies to target cardiovascular pathologies.